CN Patent

CN115605197A — 罗非考昔的新剂型和相关方法

Assigned to Temero Pharmaceutical Co ltd · Expires 2023-01-13 · 3y expired

What this patent protects

本文公开的主题涉及具有治疗益处的罗非考昔的新的剂量和剂型。

USPTO Abstract

本文公开的主题涉及具有治疗益处的罗非考昔的新的剂量和剂型。

Drugs covered by this patent

Patent Metadata

Patent number: CN115605197A
Jurisdiction: CN
Classification: —
Expires: 2023-01-13
Drug substance claim: No
Drug product claim: No
Assignee: Temero Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.